2012 annual financial data
Dare Bioscience 2012 Operating margin
Direct answer
Operating margin was -3,452%.
Operating income was -21,575,000 USD and net income was -22,101,000 USD.
Operating cash flow was -21,005,000 USD.
Get free Dare Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 625,000 USD
- Operating income
- -21,575,000 USD
- Net income
- -22,101,000 USD
- Operating cash flow
- -21,005,000 USD